CLINICAL INTERPRETATION GUIDE (NOT_VITAL MERGING, 3 DAYS)

1. Overall Performance:
- Best balanced accuracy: 0.76 (ConvTran)
- Best F1 score: 0.75 (LSTMFCN)

2. Key Findings:
- Non-viable perfection: ConvTran (BA=1.0), LSTMFCN (BA=0.99)
- >3PN excellence: ConvTran (BA/F1=1.0), LSTMFCN (F1=0.8)
- 2PN improvement: 3-day models show +12% BA over 1-day

3. Model Strengths:
- ConvTran: Unmatched in >3PN/anomalies (BA=1.0)
- LSTMFCN: Best 2PN F1=0.75
- ROCKET: Reliable 3PN detection (F1=0.84)

4. Critical Observations:
- 1.1PN remains challenging (ConvTran F1=0.0 despite BA=1.0)
- 1PN performance gap: ConvTran BA=0.82 vs LSTMFCN BA=0.67

5. Clinical Protocol:
- Automated clearance for:
  - ConvTran/LSTMFCN non-viables
  - ConvTran >3PN
- Mandatory manual inspection:
  - All 1.1PN embryos
  - 1PN from LSTMFCN
  - 3PN from ROCKET

Note: F1 Score <0.4 indicates high uncertainty, >0.7 indicates clinical reliability
